Portage Biotech Inc.

06/02/2021 | Press release | Distributed by Public on 06/02/2021 06:57

Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics’ IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting